To ask the Secretary of State for Health and Social Care, what alternatives preparations are available for people who are allergic to the contents of a covid-19 vaccine.
Chapter 14A of the UK Security Health Agency’s Green Book contains guidance on COVID-19 vaccines for health professionals. It states that anyone with a history of allergic reaction to an ingredient in a COVID-19 vaccine should not receive that vaccine, except with expert advice and should be offered an alternative if appropriate. If an individual has an allergic reaction to a first dose of vaccine, the British Society for Allergy and Clinical Immunology has advised that these individuals may be able to receive a second dose of vaccine. Many individuals have tolerated subsequent doses of the same vaccine and this is preferred as it avoids an individual being wrongly labelled as allergic for life.
For the very small number of people who are unable to receive any of the COVID-19 vaccines deployed in the United Kingdom due to allergies, there are currently no alternative immunisations available at this time. However, there are an increasing number of non-vaccine treatments now available, which lessen the impact of infection. This includes therapeutic and antiviral treatments such as Molnupiravir, Paxlovid, Ronapreve, Dexamethasone, Tocilizumab and Sarilumab.